Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 11, 2019

Amneal to buy generic pharmaceuticals provider AvKAR for $340m

Amneal Pharmaceuticals has signed an agreement to acquire a majority stake in generic pharmaceuticals provider AvKARE for an implied enterprise value of $340m.

Continue
Image: Amneal agrees to acquire generic pharmaceuticals provider AvKAR. Photo: courtesy of Jamal Abdul Nasir from Pixabay.
December 11, 2019

Dermira secures FDA fast track status for lebrikizumab in atopic dermatitis

FDA grants fast track designation to lebrikizumab in atopic dermatitis. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.
December 10, 2019

Sanofi to acquire Synthorx for $2.5bn to strengthen immuno-oncology pipeline

Sanofi to acquire US biotechnology company Synthorx. Photo: courtesy of Sanofi de/Wikimedia Commons.

Contracts

November 22, 2019

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

Image: ViiV Healthcare to develop investigational bNAbs. Photo: Courtesy of GlaxoSmithKline plc.

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

Deals

Deals December 10, 2019

Merck to buy biopharmaceutical firm ArQule for $2.7bn

Pharmaceutical Business Review

XBiotech to sell anti- IL-1⍺ antibody bermekimab to Janssen in $1.3bn deal

STADA to acquire Biopharma’s prescription and consumer health business

Astellas Pharma to buy Audentes Therapeutics for $3bn

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

7PSolutions Joins Forces with Eye-Seal’s Smart Internal Container Breach Detection Technology
7PSolutions Joins Forces with Eye-Seal’s Smart Internal Container Breach Detection Technology
30 Years One-Stop-Shop for Protein Purification and Analysis
30 Years One-Stop-Shop for Protein Purification and Analysis
Optibrium Collaborates with Enamine and BioSolveIT to Add REAL Space Search Tool to StarDrop
Optibrium Collaborates with Enamine and BioSolveIT to Add REAL Space Search Tool to StarDrop
Black Friday Special Training Offers from NSF
Black Friday Special Training Offers from NSF
Cyclica Collaborates With Enamine to Use REAL Technology in Its Ligand Design Platform for AI-augmented Drug Design
Cyclica Collaborates With Enamine to Use REAL Technology in Its Ligand Design Platform for AI-augmented Drug Design

Suppliers

Whitepapers

Oxetanes
Oxetanes
SF5-Containing Building Blocks
SF5-Containing Building Blocks
Wondering how to improve your material release process?
Wondering how to improve your material release process?